{"schema_version":"secwatch.filing_event.v1","accession":"0001285550-23-000048","form_type":"8-K","ticker":"CLPT","cik":"0001285550","company_name":"ClearPoint Neuro, Inc.","filed_at":"2023-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.264638+00:00","generated_at":"2026-06-14T18:02:18.711390+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"medium","headline":"ClearPoint Neuro amends director compensation plan effective May 22, 2023","bullets":["Board approved revisions to non-employee director compensation plan; prior version dated May 21, 2022.","Annual retainers: chair $75K, other directors $40K; committee chairs and members receive additional cash retainers.","New directors receive RSU grant valued at $135K vesting in one year; annual RSU grant also $135K for continuing directors.","Directors may elect to receive retainers in common stock in lieu of cash."],"urls":{"canonical":"https://secwatch.observer/filing/0001285550-23-000048","json":"https://secwatch.observer/filing/0001285550-23-000048.json","markdown":"https://secwatch.observer/filing/0001285550-23-000048.md","text":"https://secwatch.observer/filing/0001285550-23-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000048/0001285550-23-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000048/clpt-20230522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T18:02:18.711390+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}